Quick Answer
DNA X, Inc. reported Long Term Debt of $66.0 thousand for the year ending 2021.
- DNA X, Inc. showed a decrease of -64.3% in Long Term Debt from 2020 to 2021.
- This data is from DNA X, Inc.'s annual report (Form 10-K), filed with the SEC on March 21, 2022.
- XBRL data for this metric is available from 2018 to 2021 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: $13.10 million | Q2 2019: $13.07 million | Q3 2019: $9.79 million | Q1 2020: $325.0 thousand | Q2 2020: $325.0 thousand | Q3 2020: $222.0 thousand | Q1 2021: $148.0 thousand | Q2 2021: $111.0 thousand | Q3 2021: $74.0 thousand | Q4 2021: $66.0 thousand | Q1 2022: $30.0 thousand | Q3 2022: $37.0 thousand.
- Over the full 4 years of available data (2018 to 2021), DNA X, Inc.'s Long Term Debt has declined by 99.5%.
- Historical annual values: Fiscal year 2021: $66.0 thousand | Fiscal year 2020: $185.0 thousand | Fiscal year 2019: $362.0 thousand | Fiscal year 2018: $13.21 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: